Testing semaglutide for cocaine use disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether semaglutide, a medication used for weight management, can help reduce cocaine use in people with cocaine use disorder. You may qualify if you have a body mass index (BMI) of 25 or higher and recently used cocaine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a cocaine use disorder diagnosis and have used cocaine recently.
- Your body mass index (BMI) must be 25 or higher (overweight or obese).
- You cannot have diabetes or certain thyroid, pancreas, or kidney conditions.
- If you are a woman able to have children, you must use effective birth control and not be pregnant or nursing.
- You cannot be taking certain medications for weight loss, diabetes, or other conditions.
- You must have at least two people who can help us find you if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the diabetes drug semaglutide (also used for weight loss) can help reduce cocaine use in adults, including those living with HIV. It's free and lasts about 8 weeks.
This study tests whether the drug semaglutide (often used for weight loss) can help people who quit smoking avoid gaining weight. It's for people who are overweight or have weight-related health issues and want to stop smoking.
This trial combines deep transcranial magnetic stimulation (TMS) with a reward program (contingency management) to help people stop using cocaine. It may help if you are struggling with moderate to severe cocaine use and want a non-drug treatment.
This trial tests whether a medication called semaglutide (used for weight management) can help adults with cannabis use disorder cut down or stop using cannabis. Researchers want to see if it reduces cravings and use while also monitoring overall health.
This trial tests if semaglutide, a medication that affects appetite and cravings, can help people reduce or stop using methamphetamine. It may be a new option for those struggling with moderate to severe methamphetamine use disorder.
This study tests whether a medication called 'Glutide' (a GLP-1 agonist, similar to drugs used for diabetes) can help people who want to stop or cut down on methamphetamine. It's for those with moderate to severe meth use disorder who have used meth on at least 15 of the past 30 days.
Hear when a new Cocaine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.